FDA Alerts on Nova Biomedical StatStrip Gen 2.0 Glucose Meter Recall
The US Food and Drug Administration has issued a safety alert regarding a recall by Nova Biomedical for the StatStrip Glucose Hospital Meter System Gen 2.0. The manufacturer notified customers to remove affected devices or apply specific interim mitigation steps until a software update is available, as prior information may remain on the screen and lead to glucose results being assigned to the incorrect patient or quality control ID.
According to the manufacturer and the FDA, the issue stems from a software flaw that can cause misassignment of patient test data. This creates risks of delayed or unnecessary treatment, including inappropriate insulin administration, if clinicians act on misallocated glucose values. Critically ill patients and infants are noted to be at greater risk of adverse outcomes.
The manufacturer has implemented a shipment hold on new Gen 2.0 devices and is preparing a phased software update rollout. The FDA advises users to follow recommended mitigation settings, manually verify patient identification on screen before accepting results, log operators out after each test, and flag any incorrect entries in electronic medical records.
Key points
- Nova Biomedical recalled the StatStrip Glucose Hospital Meter System Gen 2.0 due to a software issue.
- Scanned patient or quality control barcodes may leave prior information on the screen, causing misallocated test results.
- The issue risks leading to delayed or inappropriate clinical treatment based on another patient's data.
- Interim mitigation includes verifying patient IDs on screen before acceptance, configuring automatic logoffs, and ensuring patient validation settings are active.
What it means for you
Clinicians and hospital staff using handheld blood glucose meters should remain vigilant in verifying that patient identifiers displayed on screen precisely match the individual being tested before accepting results. Erroneous electronic medical record entries must be promptly flagged and corrected according to facility procedures. Healthcare professionals in Pakistan should consult DRAP or local suppliers to verify whether this specific Gen 2.0 model is in use locally and to check for any country-specific advisories.
Hospital Glucose Meter Removal: Nova Biomedical Removes StatStrip Glucose Hospital Meter Systems
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.